鼻腔鼻窦低级别非肠型腺癌4例报道及文献复习
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Sinonasal low-grade non-intestinal-type adenocarcinoma: Report of 4 cases with literature review
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨鼻腔鼻窦低级别非肠型腺癌的临床特点及治疗方式。方法 收集分析2013—2022年于青岛大学附属医院确诊的4例鼻腔鼻窦低级别非肠型腺癌患者的临床、影像学、病理学及随访预后资料。结果 4例患者中,男1例,女3例,发病年龄33~70岁。2例查体发现右侧鼻腔肿物,1例右侧鼻塞、流涕1年余,1例左侧面部疼痛4月余。3例患者行手术治疗,1例术后接受放疗。免疫组化结果:CK7阳性表达,CK20、CDX2和villin均阴性。3例手术患者随访至今,均无复发及转移。1例未行治疗,因并发中耳癌去世。结论 鼻腔鼻窦低级别非肠型腺癌临床罕见,发病隐匿,确诊需根据病理诊断,手术治疗有效。

    Abstract:

    Objective To discuss the clinical features and treatment of sinonasal low-grade non-intestinal-type adenocarcinoma (LG non-ITAC).Methods Clinical, imaging, pathological and prognostic data of 4 sinonasal LG non-ITAC patients, who were hospitalized in the Affiliated Hospital of Qingdao University from 2013 to 2022, were retrospectively analyzed.Results The 4 patients included one male and 3 females with onset age of 33 to 70 years old. A right nasal mass was found in 2 cases, one had right nasal congestion and runny nose for more than 1 year, and one case had left facial pain for more than 4 months. Three patients underwent surgical treatment with postoperative radiotherapy in one of them. Immunohistochemistry revealed that CK7 was positively expressed, CK20, CDX2 and villin were negative. All the three patients had neither recurrence nor metastasis. The one patient without treatment died of complicated middle ear malignancy.Conclusions Sinonasal LG non-ITAC is rare in clinic. With insidious onset, its definite diagnosis depends upon histopathological eaxamination, and surgical treatment is effective.

    参考文献
    相似文献
    引证文献
引用本文

李玲玲,姜彦,葛瑞锋,宋瑞峰,曹君扬,于龙刚,李永星,袁玥,陈敏.鼻腔鼻窦低级别非肠型腺癌4例报道及文献复习[J].中国耳鼻咽喉颅底外科杂志,2023,29(5):55-59

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2022-07-04
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-31
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭